VBI Vaccines to Present at the Ladenburg Thalmann 2018 Healthcare Conference
27 sept. 2018 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Sept. 27, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...